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Abstract
In this paper we focus on proximity as one of the main determinants of international
collaboration in pharmaceutical research. We use various count data speciﬁcations
of the gravity model to estimate the intensity of collaboration between pairs of coun-
tries as explained by the geographical, cognitive, institutional, social, and cultural
dimensions of proximity.
Our results suggest that geographical distance has a signiﬁcant negative relation
to the collaboration intensity between countries. The amount of previous colla-
borations, as a proxy for social proximity, is positively related to the number of
cross-country collaborations. We do not ﬁnd robust signiﬁcant associations between
cognitive proximity or institutional proximity with the intensity of international re-
search collaboration. Moreover, there is no robust and signiﬁcant relation between
the interaction terms of geographical distance with social, cognitive, or institutio-
nal proximity, and international research collaboration. Our ﬁndings for cultural
proximity do not allow of unambiguous conclusions concerning their inﬂuence on
the collaboration intensity between countries. Linguistic ties among countries are
associated with a higher amount of cross-country research collaboration but we ﬁnd
no clear association for historical and colonial linkages.
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Collaboration has been found to be an increasingly common mode of knowledge crea-
tion. Early evidence suggests that there has been a steadily increasing trend towards
a rising number of authors in the ﬁeld of chemistry for the period from 1910 to 1960
(de Solla Price, 1963). More recently, Adams et al. (2005) showed for a broad set of dis-
ciplines that the number of authors of scientiﬁc papers originating from the 110 top U.S.
research universities increased during the 19-year period from 1981 to 1999 by 50%. Using
an extended dataset of 19.9 million papers and 2.1 million patents, Wuchty et al. (2007)
show that the phenomenon of an increasing team size in knowledge production is parti-
cularly prevalent in science and engineering, in social sciences publications, as well as in
patents, whereas it is much less evident in arts and humanities.
The general trend of an increasing number of team members in the production of know-
ledge is accompanied with a growing amount of international research. Institutional colla-
boration on the international level has become more important during the last decades as
indicated by the growing number of collaborations in research. For instance, during the
1980s, the annual growth of the share of international research collaboration was slightly
more than ﬁve percent, increasing to more than seven percent in the subsequent decade
(Adams et al., 2005). Knowledge produced by international teams is more frequently ci-
ted than research whose authors are aﬃliated to diﬀerent institutions in the same country,
and it receives particularly more citations than papers originating in a single institution
(Narin et al., 1991).
The increasing importance of the phenomena of international collaboration in scientiﬁc
research motivated us to explore its determinants. In doing so, we apply the concept of
multiple dimensions of proximity (cf. Boschma, 2005). More precisely, we aim to explain
the intensity of international collaborations in pharmaceutical research by geographical,
cognitive, institutional, social, and cultural proximity. Empirical analysis is performed
on a sample of scientiﬁc journal publications related to pharmaceutical research using
diﬀerent count data speciﬁcations of the gravity model. Our ﬁndings suggest a signiﬁcant
negative relationship between geographical distance and the collaboration intensity bet-
ween countries. The amount of previous collaborations, as a proxy for social proximity,
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signiﬁcant associations between cognitive proximity or institutional proximity with the
number of international research collaborations. Moreover, there is no robust and signiﬁ-
cant relation between the interaction terms of geographical distance with social, cognitive
or institutional proximity, and international research collaboration. Our ﬁndings for cultu-
ral proximity do not allow of unambiguous conclusions concerning their inﬂuence on the
collaboration intensity between countries. Linguistic ties among countries are associated
with a higher amount of cross-country research collaboration but we ﬁnd no clear eﬀect
for historical and colonial linkages.
The remainder of this paper is structured as follows. We describe the tendencies of
internationalization in pharmaceutical research as well as the determinants of internatio-
nal collaboration in Section 2. Section 3 provides details of the methodology and the data
used in our empirical analysis. Section 4 reports the results of the analysis of international
collaborations in the pharmaceutical research. Section 5 concludes.
2 Related Literature
2.1 Research collaboration in the pharmaceutical industry
The number of research collaborations in the pharmaceutical industry has increased after
the emergence of biotechnology in the mid 1970s for several reasons. First, the nature
of the industry’s R&D process changed from random screening to guided research. This
change has increasingly involved the application of scientiﬁc advances made by universi-
ties and public research organizations in the pharmaceutical companies’ innovation process
(McKelvey et al., 2004, Gambardella, 1995).
Second, many scientiﬁc achievements have been commercialized by new, specialized bio-
technology companies. Therefore, in-house and collaborative research became two impor-
tant ways to build up absorptive capacity, which is required to successfully incorporate
knowledge produced in academia and the biotechnology sector in the R&D projects of
pharmaceutical companies (Cockburn and Henderson, 1996, Gambardella, 1992). Conse-
quently, private sector actors can be found among the important contributors to scientiﬁc
publications in the relevant research areas, often in collaboration with academic partners
2
Jena Economic Research Papers 2011 - 026(Tijssen, 2004).
Third, as a result of the industry’s expanding knowledge base, it became too broad to
be available in all details to one single organization. Therefore, collaboration is seen now
as a channel through which external knowledge can be accessed (cf. Orsenigo et al., 2001).
Collaboration in pharmaceutical R&D extends beyond national borders. For instance,
European pharmaceutical companies not only have established R&D centers outside their
home countries, but are connected to a considerable number of international research
partners (Tijssen, 2009). Similarly, in almost one quarter of corporate research collabora-
tions, ﬁrms and institutions from more than three world regions are involved (Calero et al.,
2007).
This trend of internationalization of research collaboration has been promoted particularly
by large technology-based multinationals intending to source knowledge at a global scale
through the location of their R&D activities at a few technologically and scientiﬁcally lea-
ding global centers of excellence (Gassmann and von Zedtwitz, 1999). In this way, compa-
nies have established a network of specialized research activities across countries in order
to get access to locally based technological and scientiﬁc expertise (Cantwell and Janne,
2000).
2.2 Determinants of Collaboration
Given the increasing importance of collaboration in the pharmaceutical industry, we ask
what determines this phenomenon on the international level. Put diﬀerently, we aim to
explain why researchers from one country collaborate with colleagues in some countries,
but not with those from others.
One argument raised in the literature is that knowledge production and knowledge spillo-
vers are geographically bounded within the region of creation (Audretsch and Feldman,
1996, Jaﬀe et al., 1993). Particularly the transfer of tacit knowledge, often involved in
R&D processes, is done best through face-to-face interaction, which is facilitated by close
spatial distances.
Geographical proximity has been found to be an important factor determining the extent
of international scientiﬁc collaboration (Ponds et al., 2007, Luukkonen et al., 1992). Ho-
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collaboration, we do not only refer to geographical distance between countries. Instead,
we follow Boschma (2005) who draws upon the French School of Proximity Dynamics in
suggesting that proximity is multidimensional. More precisely, we focus our analysis on
geographical, cognitive, institutional, and social proximity. We also explore the linguistic
and historical ties between countries in order to account for an additional dimension of
proximity: cultural proximity.
In order to isolate geographical from other dimensions of proximity its deﬁnition is restric-
ted to the spatial or physical distances between economic actors (Boschma, 2005). The
distance can be expressed in absolute terms, e.g., in kilometers, or in relative terms, e.g.,
travel times. Short distances between economic actors facilitate personal contacts, the
exchange of information, and particularly tacit knowledge. Hence, geographical proximity
may facilitate inter-organizational learning but is not a prerequisite for collaboration and
learning since other proximity dimensions may act as substitutes. On the other hand,
geographical proximity may also be complementary to social, organizational, institutio-
nal, and cognitive proximity and enhance interaction, knowledge creation and innovation
more indirectly (Boschma, 2005, Howells, 2002). The literature suggests that geogra-
phical proximity is an important determinant of research collaborations on the regional
level in Europe and is particularly important for cooperative work in the life sciences
(Hoekman et al., 2009, 2010, Ponds et al., 2007). We argue that this relation should hold
also on the level of international collaborations. Therefore, our ﬁrst hypothesis is
Hypothesis 1 Geographical distance is negatively related to the intensity of international
research collaborations.
In an evolutionary perspective, knowledge creation and innovation often imply a high
degree of tacit knowledge and can be seen as the cumulative outcome of search processes
conducted by boundedly rational agents. The creation of new knowledge and the learning
about existing knowledge depends in many instances on the combination of diverse but
complementary capabilities within and between organizations (Nooteboom, 2000). The
tacit and idiosyncratic component of knowledge implies that besides access, absorptive
capacity enables actors to identify, interpret, and exploit new knowledge. Hence, it is a
precondition for eﬀective knowledge transfer (Cohen and Levinthal, 1990). Given these
4
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ledge. Cognitive proximity means the suﬃcient closeness of an actor’s cognitive base
towards new knowledge in order to permit successful communication, understanding, and
absorption (Boschma and Lambooy, 1999).
An empirical test of the relation between cognitive proximity and ﬁrm cooperation de-
monstrated that an overlap in ﬁrms’ knowledge stocks is associated with a higher proba-
bility of cooperation (Cantner and Meder, 2007). We would like to ask whether cognitive
proximity has a similar importance in international collaborations.
Hypothesis 2 Cognitive proximity has a positive relation with the intensity of interna-
tional research collaboration.
Institutional proximity refers to the institutional environment at the macro-level. In
this sense, institutions refers to ‘sets of common habits, routines, established practices,
rules or laws that regulate the relations and interactions between individuals and groups’
(Edquist and Johnson, 1997). Formal, e.g., laws, and informal, e.g., cultural norms, ins-
titutions inﬂuence the manner of and the extent of collaboration. Institutional proximity
has been regarded as an enabling factor that provides stable conditions for eﬀective in-
teractive learning. Gertler (1995) shows that institutional diﬀerences at the macro-level,
i.e., in this case job training and workplace practices, can hinder cross-border interactions
among ﬁrms. Based on these arguments we build our hypothesis concerning the impact
of institutional proximity on the country-level.
Hypothesis 3 Institutional proximity is positively related with the number of internatio-
nal research collaborations.
The notion of social proximity draws upon the embeddedness literature, which suggests
that economic activities are embedded in a social context (Granovetter, 1985). The extent
of this embeddedness is connected to organizational learning and innovative performance.
Building upon these thoughts, social proximity is deﬁned in terms of socially embedded
relations, i.e., it involves trust based on friendship, kinship, and experience, between
agents at the micro-level (Boschma, 2005). On the one hand, social proximity may enhance
interactive learning and knowledge creation through mutual trust and commitment. On
the other hand, there is the danger of lock-in and the risk of opportunism. On the ﬁrm
level, it has been argued that ﬁrms often connect due to a common work experience of their
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too.
Hypothesis 4 Social proximity is positively related to the intensity of international re-
search collaborations.
Similar to the institutional dimension of proximity, cultural proximity reﬂects a common
cultural background. A common cultural space is among others formed by a common
working tradition, a common language, mutual trust, and mutually respected norms of
behaviour (Zeller, 2004). Cultural proximity has been found to facilitate social proximity.
The presence of cultural diﬀerences impedes the transmission and decoding of certain
types of messages, especially if tacit components are involved (Lundvall, 1992). Empi-
rical studies reveal that linguistic and historical ties inﬂuence the intensity of scientiﬁc
collaboration (Zitt et al., 2000). Therefore, we formulate our hypothesis concerning the
impact of cultural proximity as follows:
Hypothesis 5 Cultural proximity is positively related with the intensity of international
research collaboration.
3 Data and Research Methodology
3.1 Gravity Model
We analyse the determinants of collaboration among diﬀerent countries using a gravity
model. Early applications of gravity models in economics were focused on the analysis of
international trade ﬂows (e.g. Isard, 1954, Tinbergen, 1962). Later this model has been
applied to a broad variety of research questions. In the context of research collaborations,
it has been used to analyse the intensity of co-publications among regions (Hoekman et al.,
2010, 2009). The basic idea of the gravity model can be traced back to Newton’s law
of universal gravitation which states that the gravitational force between two objects
is proportional to the product of the masses of the objects and the distance between
them. The basic gravity equation can be expressed as follows (cf. Burger et al., 2009,
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ween countries i and j. β0 is a proportionality constant. Mi and Mj represent the masses
of country i and j, which are in our case the number of publications. The distance bet-
ween the two countries is denoted by dij. β1,2 reﬂect the potential to collaborate and β3
reﬂects the eﬀect of distance. The multiplicative form of the gravity model presented in
(1) can be transformed to a testable linear model by taking the logarithms of both sides
and adding a disturbance term ǫij:
lnIij = lnβ0 + β1 lnMi + β2 lnMj − β3 lndij + ǫij (2)
Concerning the estimation of (2) we have to take into account that we are dealing with
count data. Hence, the OLS framework is not appropriate and we apply alternative
regression techniques: the Poisson and negative binomial models, based on maximum
likelihood techniques (Burger et al., 2009, Flowerdew and Aitkin, 1982). In a Poisson
regression framework, the observed volume of research collaboration between i and j is







,(Iij = 0,1,...) (3)
The conditional mean  ij is linked to an exponential function of the regression variables:
 ij = exp(β0 + β1 lnMi + β2 lnMj + β
′ lnDij) (4)
In (4), β0 is a constant, Dij is the vector of explanatory variables representing diﬀerent
dimensions of distance, and β′ is the corresponding parameter vector. An important
caveat of the Poisson model is the assumption of equidispersion, which means that the
variance equals the mean. In order to correct for the violation of this assumption we
employ a negative binomial regression model, which can be seen as a modiﬁed Poisson






α−1 +  ij
￿α−1 ￿
 ij
 ij + α−1
￿Iij
(5)
where  ij is the conditional mean, Γ is the gamma function, and α is the parameter
determining the degree of dispersion, allowing that the conditional variance exceeds the
conditional mean. Larger α corresponds to a larger degree of overdispersion in the data.
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regression model.
Another problem prevalent in many practical applications of Poisson and negative bino-
mial estimation is an excessive number of zeros in the data. In other words, the problem
arises when the number of zero counts is greater than what the Poisson or the negative
binomial distribution would predict. In order to overcome this problem, zero-inﬂated
versions of both Poisson and negative binomial models may be applied.
The basic idea behind a zero-inﬂated model is that zero values are generated by a dif-
ferent process than the positive ones. The ﬁrst part of a zero-inﬂated model consists of
a binary process, which in our empirical application is a logit model. The dependent
variable in this logit model takes the value zero when there is no collaboration between
the respective countries in a certain therapeutic area. If the binary process equals one,
the number of collaborations is equal to or greater than zero. In the second part of the
estimation, a Poisson or negative binomial regression model is applied to estimate the
collaboration intensity. Hence, zeros can be the outcome of both the binary process and
the count process, given that the binary process takes the value one. We can express the
zero-inﬂated Poisson model as
Pr[Iij = 0] = ψij + (1 − ψij)exp(− ij) (6)






where (6) refers to the ﬁrst part and (7) to the second. ψ is the proportion of observations
with a strictly zero count determined by the logit model (cf. Burger et al., 2009). When
ψ equals zero, the model reduces to the Poisson model. Along similar lines we can deﬁne
the zero-inﬂated negative binomial regression model:
Pr[Iij = 0] = ψij + (1 − ψij)
￿
α−1
α−1 +  ij
￿α−1
(8)





α−1 +  ij
￿α−1 ￿
 ij
α−1 +  ij
￿Iij
(9)
For both versions of the zero-inﬂated model, the Vuong test statistic can be used to test
whether the zero-inﬂated model is favoured above the respective uninﬂated versions, by
analysing if there is signiﬁcant evidence for excessive zero counts (Vuong, 1989).
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In our empirical analysis we use data from diﬀerent sources. We start by drawing a list
of 251 medical indications from BioPharmInsight.1 Each indication represents a condi-
tion, disease or symptom. Each indication is exclusively assigned to one of 15 therapeutic
areas.2 Therapeutic areas are deﬁned according to a system of an organism or a general
disease group. Examples of therapeutic areas are “Central Nervous System” and “Infec-
tious Diseases”.
This list of medical indications (or diseases) was used to search for corresponding scientiﬁc
pharmaceutical publications in the Web of Science databases (WoS). The WoS consists
of seven databases containing information gathered from an extensive number of jour-
nals, books, book series, reports, and conferences. In the case of the Friedrich-Schiller-
University of Jena, it is hosted by Thomson Reuters. Among these databases, the most
important one is the Science Citation Index Expanded. It is multidisciplinary and indexes
more than 6,500 scientiﬁc journals and covers 150 scientiﬁc disciplines. The Science Ci-
tation Index Expanded covers, among others scientiﬁc ﬁelds, biochemistry, medicine, and
pharmacology, which are of particular interest for our study.
The WoS contains information concerning the scientiﬁc publications themselves, such as
the title, the year of publication, the journal, cited references, a categorization of the
research ﬁelds a publication can be assigned to, and further bibliographic information.
In addition to this information, the Web of Science reports for most articles the authors’
aﬃliations, including the country of the location of a respected organization.
Scientiﬁc publications in the database were searched for the occurrence of each of 251 me-
dical indications in their title. We consider all publications included in categories related
to pharmaceutical research. Articles from the subcategories “Biochemistry & Molecular
Biology”, “Biotechnology and Applied Microbiology”, “Chemistry, Applied”, “Chemistry,
Medicinal”, “Medicine, Research & Experimental”, “Pharmacology & Pharmacy”, and
“Toxicology” are included in our dataset.3 We restrict our sample to journal articles and
exclude publications that are labeled as meeting abstracts, editorials or reviews as well as
1http://www.inﬁnata5.com/biopharm/
2Table 3 provides an overview of the therapeutic areas included in the dataset.
3The subcategories are described in detail at http://scientiﬁc.thomsonreuters.com/mjl/.
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since they might be of diﬀerent quality compared to published papers or may be already
included as published articles. For the period from 1974 to 2008 we obtain 211,661 publi-
cations. Unfortunately, prior to 1998 information concerning the authors’ aﬃliations was
not included in the WoS for a considerable number of cases. Therefore, we concentrate
on the years from 1998 to 2008 which encompass 113,057 articles. After selecting articles
which contained the authors’ aﬃliations, we had a sample of 111,096 journal articles. An
additional 66,312 journal articles published between 1974 and 1997 for which we could
identify author aﬃliations were used to construct a proxy for the amount of collaboration
between countries in the diﬀerent therapeutic areas prior to the periods of observation in
our sample.
Information concerning the authors’ aﬃliations is matched with WHO Regions and World-
bank income groups in order to include the geographical region a country is located in
and the wealth level of the countries in our sample. Since the WHO Regions do not
classify all countries included in our database, we assign previously unclassiﬁed countries
to additionally created regional groups. More precisely we create groups for the members
of the EU-15, the United States and Canada (North America), as well as for Australia
and New Zealand (Australasia), Japan, and Switzerland.
We use the CHI classiﬁcation of journals (Hamilton, 2003) to classify each article accor-
ding to the type of research prevalent in the journal it is published in. By using this
classiﬁcation scheme we can distinguish “clinical observation”, “clinical mix”, “clinical
investigation”, and “basic biomedical research”.
We employ the CEPII (Centre d’´ Etudes Prospectives et d’Information Internationales)
database on distance measures (Mayer and Zignago, 2006). The database includes dif-
ferent measures for geographical distances between most countries of the world. This
dataset allows us to control for additional sources of proximity among countries, based on
the same language, colonial linkages, or shared history as parts of the same country. In
order to get additional information concerning the institutional environment in diﬀerent
countries, we use the “Index of Economic Freedom” for the years 1996 to 2008, created
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the degree of economic freedom in ten subﬁelds ranging from property rights to entrepre-
neurship for (currently) 183 countries.
The use of publication data implies the advantage of getting access to highly detailed
information covering a long time span. Some of the major drawbacks are that research
does not necessarily lead to publications, co-authorship may only partly capture scien-
tiﬁc collaboration, the impact of publications diﬀers considerably, and publication ha-
bits diﬀer among scientiﬁc disciplines. Moreover, publication databases may be biased
towards English language publication originating in industrialized countries. Although
co-publication data is associated with the mentioned shortcomings, it has been found to
be an appropriate indicator for scientiﬁc collaboration (see, e.g., Katz and Martin (1997),
Laudel (2002), Lundberg et al. (2006), and Hoekman et al. (2009) for a discussion).
4 Empirical Results Gravity Regression Model
4.1 Variables and Descriptives
The dependent variable in the gravity model is the amount of collaboration between two
countries.5 In order to construct a proxy for the collaboration intensity, we assign each
publication to the respective countries mentioned in the authors’ aﬃliations. The de-
pendent variable is then calculated as the number of co-publications between each pair of
countries. We distinguish the collaboration intensity for each therapeutic area and each
sub-period. We use full counting which implies that a publication that can be assigned
to three diﬀerent nations leads to an interaction intensity between each country pair of
one. Since co-publications represent undirected links, we include each pair of countries
only once in our analysis.
As we have pointed out, the gravity model assumes that the interaction between two
countries depends on their masses. In order to derive a proxy for the mass of a country
we count the total number of publications per country in the respective period. The
4http://www.heritage.org/index/
5Appendix A.1 provides a description of the variables.
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the dependent variable, we consider publications per therapeutic area.
Geographical proximity (log distw) is calculated based on city-level data in order to ac-
count for the geographic distribution of the population inside each nation. The distance
between two countries is calculated based on bilateral distances between the biggest cities
of the two nations. These inter-city distances are weighted by the share of the city in
the overall population and enter as logs in our regression models (cf. Mayer and Zignago,
2006).
In correspondence with the deﬁnition of social proximity we calculate the number of
cumulated previous collaborations (log PrevExperience) as a proxy for this dimension of
proximity. In doing so, we account for the possibility that researchers from diﬀerent
organizations located in diﬀerent nations have established collaborations during our two
periods of observation based on previous experience from joint research projects. Further-
more, we may also account for formal and informal ties between organizations by applying
this measure of previous experience. Before taking the log we add one to this proxy. The
variable distExp represents the interaction term between the population weighted geogra-
phical distance and our proxy for social proximity.
Our measure of cognitive proximity (log PrevSpecialCorr) is based on the specialization
proﬁles of countries among therapeutic areas prior to the analysed period. Following the
idea of Jaﬀe (1986) and Peri (2005), we construct a vector containing the shares of publi-
cations in each therapeutic area per country prior to the analysed period. We calculate the
uncentred correlation, which corresponds to the cosine, of these vectors for each country
pair and take the log. We additionally include the interaction term between the popu-
lation weighted geographic distance and our measure for cognitive proximity (distSpecial).
Our measure of institutional proximity (log PrevResTypeCorr) is constructed along si-
milar lines. We calculate the uncentred correlation of the country vectors containing the
share of diﬀerent research types according to the CHI classiﬁcation, i.e., ”clinical obser-
vation”, ”clinical mix”, ”clinical investigation”, and ”basic biomedical research”, lag the
respective vectors by one period and take the log. In doing so we account for diﬀerences
12
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include the interaction term between the population weighted geographical distance and
our measure for institutional proximity in our analysis (distResType).
We account for cultural proximity by including a set of dummy variables indicating if
at least 9% of the population in both countries share the same language (comlang ethno),
if two countries have ever had a colonial link (colony), had the same colonizer after 1945
(comcol), or were part of the same country (smctry). Moreover, we control for whether two
countries are adjacent (contig) and belong to the same Worldbank income group (SmIn-
comeGr). Furthermore, we add a dummy indicating whether the collaboration took place
in period 2 (2004 to 2008). When we distinguish the amount of collaboration among the-
rapeutic areas, we add dummy variables for the diﬀerent therapeutic areas to our analysis.
Figure 1 illustrates the development of cross-country collaborated research articles over
time. Similar to many other studies we ﬁnd an increasing share of international research
collaboration. Nevertheless, we ﬁnd that by 2008 almost 72% of the collaborations in
our sample take place within national borders6. There are considerable diﬀerences in
the frequency of international collaboration among WHO regions and Worldbank income
groups. In contrast to publications from Europe, North America and Japan, we ﬁnd that
articles from Switzerland and Sub-Saharan Africa show particularly high shares of inter-
national collaborations. With respect to income groups, our descriptive results suggest
that organizations from low income countries are particularly engaged in international col-
laborations if they publish scientiﬁc articles, whereas organizations from OECD member
states do not engage extensively in cross-country collaboration.
4.2 Regression Results
We start our empirical analysis with Poisson regression models7. However, in contrast to
the assumptions made in the Poisson framework, the variance of the dependent variable
exceeds the mean for our sample, implying overdispersion. Using the test proposed by
Cameron and Trivedi (1990), we ﬁnd signiﬁcant overdispersion in most model speciﬁca-
6See Figures 2 and 3 in the Appendix for a more detailed illustration.
7Results not presented in this paper are available upon request.
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Jena Economic Research Papers 2011 - 026Figure 1: Share of Cross-Country Collaborations per Year
tions. Therefore, we account for the possibility of overdispersion by using robust standard
errors and by applying negative binomial regressions, which have been established as the
standard alternative to the Poisson model.
In Table 1 we distinguish the number of publications and collaborations according to
the 15 therapeutic areas included in our study. As in many applications of count data,
the data on cross-country research collaborations shows an excessive number of zeros. Wi-
thout distinguishing among therapeutic areas, 10,975 out of 14,016 observations are zero
counts, with the distinction 34,131 out of 42,999 observations are zeros. These are, respec-
tively, 78.3% and 79.4%. We deal with this data structure by estimating a zero inﬂated
version of the negative binomial model, presented in Table 2. The Vuong test (Vuong,
1989) suggests preferring the zero-inﬂated models over their ordinary counterparts. The
goodness-of-ﬁt statistics indicates that the zero-inﬂated negative binomial model is most
suitable for our dataset since it has the highest value of the log-pseudolikelihood and the
smallest values of the Akaike criterion (AIC) and the Baysian Information Criterion (BIC).
Tables 1 and 2 give the results of our empirical estimation. We test our hypothesis
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Our proxies for the masses log PubActor and log PubPartner, i.e., the number of publi-
cations assigned to each country, have a positive sign and are signiﬁcant, which implies
that the number of publications is positively related with the intensity of scientiﬁc colla-
boration.
Similar to other studies in the ﬁeld, we ﬁnd that the population weighted distance between
countries, log distw, as a proxy for geographical distance has a negative and highly signiﬁ-
cant association with the number of cross-country collaborations. In other words, we ﬁnd
that the collaboration intensity decreases with spatial distance which corresponds to our
expectations formulated in hypothesis 1. A possible explanation for this ﬁnding is that
geographic distance impedes face-to-face interaction which is particularly important for
scientiﬁc collaboration involving the transfer of tacit knowledge. Hence, researchers colla-
borate more intensively with partners in countries that are close to their country of origin.
Our measure for social proximity, log PrevExperience, is positively related to the amount
of collaboration among country pairs. This ﬁnding indicates that previous experience
through research collaborations with partners in the respective country is positively re-
lated to the extent of collaboration in the two periods of observation. Hence, hypothesis
4 cannot be rejected. Therefore, this ﬁnding suggests that researchers and organizations
are more likely to connect to colleagues and institutions from abroad if they have some
common experience with them, since it reduces uncertainty and the risk of opportunism.
The coeﬃcient for cognitive proximity (log PrevSpecialCorr) changes its sign. It is posi-
tive, although not always signiﬁcant, in the negative binomial models. In the zero-inﬂated
models, however, we do not ﬁnd a robust positive association since the coeﬃcient is not
always signiﬁcant, and is negative in several model speciﬁcations. Therefore, hypothesis
2 stating a positive relationship has to be rejected. In other words, this ﬁnding does not
indicate that international research collaborations are established among countries that
are specialized in the same therapeutic areas. It may be that the cognitive basis of the
countries in our dataset is suﬃciently close since otherwise actors located in the respective
countries would not be able to publish in international scientiﬁc journals. Hence, similar
specialization patterns in diﬀerent disease areas may not be a precondition for mutual
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The results for institutional proximity proxied by log PrevResTypeCorr do not indicate
a robust and signiﬁcant positive association with the number of international research
collaborations. The coeﬃcient of this variable is not signiﬁcant in most model speciﬁca-
tions and changes its sign quite frequently. Based on this ﬁnding we reject hypothesis 3
suggesting a positive relationship between cognitive proximity and the number of inter-
national research collaborations. Our ﬁndings indicate no clear relation between similar
institutional settings in the research sector, i.e., a specialization in a certain type of phar-
maceutical research, and the intensity of collaboration. Hence, institutional proximity
among countries may not necessarily facilitate interaction and joint research projects.
With respect to our measures for cultural proximity we ﬁnd that a common language
(comlang ethno) between two countries is positively associated with the number of col-
laborated research articles. One could have expected that a common language is less
important for international research collaboration since English has a dominant position
as the language of science and dominates by far the language of the articles in our dataset.
However, our results show that researchers may prefer to discuss scientiﬁc problems with
their collaboration partners in their mother tongue.
We ﬁnd inconclusive evidence concerning the variables accounting for colonial ties ex-
pressed by colony and comcol on the number of research collaborations. Similarities in
countries’ (informal) institutional settings based on a joint colonial history may facilitate
collaboration, but we do not ﬁnd support for this idea in our regression models. Along
similar lines one could argue that collaboration between nations that were part of one
country in the past may be facilitated since there should be linguistic as well as cultural
links and knowledge about each others informal institutions. However, our results for
smctry do not suggest a robust, signiﬁcant positive relation of a joint history within one
country. With respect to hypothesis 5, we ﬁnd support for the positive relation of cultural
proximity on cross-country research collaboration only for linguistic ties. We ﬁnd no ro-
bust evidence that colonial and other historical ties are positively related to international
research collaboration.
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ciated with the amount of research collaborations, particularly if we distinguish between
therapeutic areas. The result may indicate that researchers may aim to connect to global
centers of excellence which may not be located in an contiguous nation. The coeﬃcient
for SmIncomeGr, indicating whether two countries are part of the same income group, is
positive and highly signiﬁcant in all model speciﬁcations. This may indicate that countries
on a similar stage of economic development share a similar knowledge base and therefore
intensify collaboration. It may also be that similar economic conditions and livings stan-
dards are associated with the prevalence of similar diseases in the respective countries
leading to intensiﬁed collaboration.
We additionally included the interaction terms between geographical distance and the
social, cognitive and institutional dimensions of proximity in our analysis. Our results do
not suggest a robust and signiﬁcant association between the interaction terms, distExp,
distSpecial, distResType, and the number of international research collaborations. Conse-
quently, our results do not suggest a complementarity between geographical and other
dimensions of proximity.
To summarize, our results suggest that geographical distance is signiﬁcantly and ne-
gatively related to the collaboration intensity between countries whereas the amount of
previous collaborations (social proximity) is positively related to the number of cross-
country collaborations. Hence, our results support hypotheses 1 and 4. With respect to
the cognitive dimension of proximity, we do not ﬁnd evidence for a robust and signiﬁcant
relation to the intensity of international research collaborations. Therefore, we reject hy-
pothesis 2. Similarly, we reject hypothesis 3 since our estimations do not suggest a robust
signiﬁcant relationship between institutional proximity and the number of research colla-
borations. Our results for cultural proximity do not allow for unambiguous conclusions
concerning their inﬂuence on the collaboration intensity between countries and have to
be analysed in more detail as we do not ﬁnd unambiguous support for hypothesis 5.
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98-02 98-02 98-02 04-08 04-08 04-08 Pooled Pooled Pooled
Dependent Variable: Number of Collaborations
log PubActor 0.517∗∗∗ 0.522∗∗∗ 0.529∗∗∗ 0.549∗∗∗ 0.551∗∗∗ 0.560∗∗∗ 0.536∗∗∗ 0.540∗∗∗ 0.547∗∗∗
log PubPartner 0.500∗∗∗ 0.502∗∗∗ 0.509∗∗∗ 0.535∗∗∗ 0.535∗∗∗ 0.543∗∗∗ 0.522∗∗∗ 0.523∗∗∗ 0.529∗∗∗
log distw -0.625∗∗∗ -0.667∗∗∗ -0.785∗∗∗ -0.629∗∗∗ -0.653∗∗∗ -0.799∗∗∗ -0.631∗∗∗ -0.664∗∗∗ -0.796∗∗∗
log PrevExperience 0.671∗∗∗ 0.638∗∗∗ 0.236∗ 0.633∗∗∗ 0.608∗∗∗ 0.286∗∗∗ 0.641∗∗∗ 0.611∗∗∗ 0.263∗∗∗
log PrevSpecialCorr 0.277 0.360 9.765∗∗∗ 0.764∗∗∗ 0.777∗∗∗ 5.724∗∗∗ 0.583∗∗∗ 0.622∗∗∗ 7.913∗∗∗
log PrevResTypeCorr 2.689 2.530 -0.375 -0.0353 -0.00226 3.245∗∗∗ -0.0212 0.0113 2.857∗∗∗
comlang ethno 0.927∗∗∗ 0.927∗∗∗ 0.474∗∗∗ 0.467∗∗∗ 0.694∗∗∗ 0.685∗∗∗
colony 0.274 0.328∗ 0.472∗∗∗ 0.502∗∗∗ 0.373∗∗∗ 0.415∗∗∗
comcol -0.493 -0.443 0.0258 0.117 -0.171 -0.0905
smctry 0.333 0.344 0.309 0.396 0.312 0.355∗
distExp 0.0517∗∗∗ 0.0373∗∗∗ 0.0422∗∗∗
distSpecial -1.108∗∗∗ -0.579∗∗ -0.855∗∗∗
distResType 0.296 -0.370∗∗∗ -0.321∗∗∗
contig -0.185 -0.557∗∗ -0.522∗∗ -0.481∗∗∗ -0.726∗∗∗ -0.663∗∗∗ -0.351∗∗∗ -0.656∗∗∗ -0.597∗∗∗
SmIncomeGr 0.550∗∗∗ 0.626∗∗∗ 0.580∗∗∗ 0.314∗∗∗ 0.347∗∗∗ 0.319∗∗∗ 0.430∗∗∗ 0.478∗∗∗ 0.438∗∗∗
Period Control No No No No No No Yes Yes Yes
Therap. Area Controls Yes Yes Yes Yes Yes Yes Yes Yes Yes
cons 0.399 0.591∗∗ 1.496∗∗∗ 0.0866 0.193 1.374∗∗∗ 0.198 0.344∗ 1.397∗∗∗
lnalpha
cons 1.377∗∗∗ 1.337∗∗∗ 1.305∗∗∗ 1.022∗∗∗ 0.998∗∗∗ 0.977∗∗∗ 1.185∗∗∗ 1.156∗∗∗ 1.130∗∗∗
N 23182 23182 23182 19817 19817 19817 42999 42999 42999
AIC 36406.1 36120.8 36034.2 48123.8 47960.8 47845.4 84807.4 84363.3 84156.0
BIC 36599.3 36346.2 36283.8 48313.3 48181.9 48090.1 85024.1 84614.7 84433.4
Log pseudolikelihood -18179.061 -18032.404 -17986.103 -24037.918 -23952.419 -23891.69 -42378.681 -42152.638 -42046.005
∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001
Table 1: Negative Binomial Regression Models With Therapeutic Area Distinction
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98-02 98-02 98-02 04-08 04-08 04-08 Pooled Pooled Pooled
Dependent Variable: Number of Collaborations
log PubActor 0.385∗∗∗ 0.398∗∗∗ 0.409∗∗∗ 0.433∗∗∗ 0.439∗∗∗ 0.450∗∗∗ 0.418∗∗∗ 0.428∗∗∗ 0.437∗∗∗
log PubPartner 0.367∗∗∗ 0.379∗∗∗ 0.394∗∗∗ 0.422∗∗∗ 0.428∗∗∗ 0.438∗∗∗ 0.405∗∗∗ 0.413∗∗∗ 0.423∗∗∗
log distw -0.469∗∗∗ -0.511∗∗∗ -0.583∗∗∗ -0.491∗∗∗ -0.512∗∗∗ -0.550∗∗∗ -0.489∗∗∗ -0.520∗∗∗ -0.571∗∗∗
log PrevExperience 0.476∗∗∗ 0.462∗∗∗ 0.457∗∗∗ 0.512∗∗∗ 0.498∗∗∗ 0.566∗∗∗ 0.485∗∗∗ 0.471∗∗∗ 0.504∗∗∗
log PrevSpecialCorr -0.551∗∗ -0.519∗∗ 13.73∗∗∗ 0.121 0.119 7.366∗∗∗ -0.190 -0.170 9.963∗∗∗
log PrevResTypeCorr -0.0175 -0.334 1.379 -0.223∗∗∗ -0.202∗∗∗ 2.939∗∗∗ -0.121 -0.103 2.668∗∗∗
comlang ethno 0.599∗∗∗ 0.585∗∗∗ 0.252∗∗∗ 0.248∗∗∗ 0.425∗∗∗ 0.411∗∗∗
colony -0.0377 0.0205 0.249∗∗ 0.302∗∗∗ 0.124 0.183∗∗
comcol -0.127 -0.0801 0.334∗ 0.385∗ 0.154 0.224
smctry 0.430∗ 0.500∗ 0.372∗ 0.489∗ 0.375∗∗ 0.459∗∗
distExp -0.00138 -0.0137 -0.00824
distSpecial -1.726∗∗∗ -0.856∗∗∗ -1.208∗∗∗
distResType -0.324 -0.355∗∗∗ -0.311∗∗∗
contig -0.412∗∗∗ -0.728∗∗∗ -0.618∗∗∗ -0.557∗∗∗ -0.777∗∗∗ -0.662∗∗∗ -0.483∗∗∗ -0.745∗∗∗ -0.635∗∗∗
SmIncomeGr 0.438∗∗∗ 0.512∗∗∗ 0.508∗∗∗ 0.267∗∗∗ 0.297∗∗∗ 0.304∗∗∗ 0.360∗∗∗ 0.403∗∗∗ 0.399∗∗∗
Period Control No No No No No No Yes Yes Yes
Therap. Area Controls Yes Yes Yes Yes Yes Yes Yes Yes Yes
constant 1.233∗∗∗ 1.320∗∗∗ 1.726∗∗∗ 0.708∗∗∗ 0.763∗∗∗ 1.013∗∗∗ 0.926∗∗∗ 1.007∗∗∗ 1.340∗∗∗
Zero-inﬂated Part (logit)
log distw 0.221∗∗∗ 0.200∗∗∗ 0.279∗∗∗ 0.239∗∗∗ 0.220∗∗∗ 0.347∗∗∗ 0.221∗∗∗ 0.202∗∗∗ 0.297∗∗∗
log PrevExperience -1.895∗∗∗ -1.876∗∗∗ -1.883∗∗∗ -1.350∗∗∗ -1.344∗∗∗ -1.369∗∗∗ -1.636∗∗∗ -1.628∗∗∗ -1.637∗∗∗
log PrevSpecialCorr -2.199∗∗∗ -2.182∗∗∗ -2.418∗∗∗ -1.641∗∗∗ -1.646∗∗∗ -1.705∗∗∗ -1.904∗∗∗ -1.899∗∗∗ -2.000∗∗∗
log PrevResTypeCorr -5.276∗∗∗ -5.560∗∗∗ -5.934∗∗∗ -0.594∗∗∗ -0.582∗∗∗ -0.497∗∗∗ -0.255∗∗∗ -0.252∗∗ -0.197∗
constant -1.150∗∗∗ -1.056∗∗∗ -1.758∗∗∗ -1.841∗∗∗ -1.710∗∗∗ -2.759∗∗∗ -1.363∗∗∗ -1.257∗∗∗ -2.056∗∗∗
lnalpha
constant 0.400∗∗∗ 0.413∗∗∗ 0.381∗∗∗ 0.247∗∗∗ 0.239∗∗∗ 0.219∗∗∗ 0.344∗∗∗ 0.348∗∗∗ 0.319∗∗∗
N 23182 23182 23182 19817 19817 19817 42999 42999 42999
AIC 34939.5 34816.9 34684.4 46793.7 46712.1 46556.2 82072.0 81865.6 81588.3
BIC 35172.9 35082.6 34974.2 47022.7 46972.6 46840.4 82332.1 82160.4 81909.0
Log pseudolikelihood -17440.73 -17375.44 -17306.19 -23367.87 -23323.06 -23242.12 -41006.02 -40898.8 -40757.14
∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001
Table 2: Zero-inﬂated Negative Binomial Regression Models With Therapeutic Area Distinction
1
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collaboration counts and if we do not add 1 to the measure for social proximity. We
account for the possibility that our results are driven by collaboration among developed
countries by excluding all country pairs with at least one OECD country involved from our
analysis. We ﬁnd that our results stay qualitatively the same in this case, too. Since our
measure for institutional proximity is restricted to the research environment and may face
classiﬁcation problems we use the “Index of Economic Freedom” as an alternative measure
for the institutional settings on the macro level. In order to account for institutional
proximity, we calculate the uncentred correlation of country vectors containing the average
of the subindices of economic freedom for the respective years and take the log. The
regression results stay qualitatively the same for this alternative proxy.
5 Conclusion
In this paper we tested empirically the determinants of cross-country collaborations in
pharmaceutical research. We focused our attention on the diﬀerent dimensions of proxi-
mity in order to explain the intensity of international collaborations.
As our results suggest, some dimensions of proximity are important in explaining col-
laboration on the country level. Countries close in geographical and social proximity
dimensions show higher levels of international collaboration. Our empirical analysis does
not indicate a robust signiﬁcant association between the cognitive and institutional di-
mension of proximity the number of international research collaborations. Furthermore,
the interaction terms of geographical distance and social, cognitive and institutional dis-
tance do not indicate a signiﬁcant relation to the number of research collaborations on the
country level. With respect to cultural proximity our results are inconclusive. Linguistic
ties among countries are associated with a higher amount of cross-country research colla-
boration whereas we ﬁnd no clear eﬀect for historical and colonial linkages.
Our ﬁndings for the geographical and social dimensions of proximity are in line with
previous ﬁndings in the literature (see e.g. Frenken et al., 2009). In contrast to theory,
see e.g., Boschma (2005), the results of our empirical analysis do not indicate a signiﬁcant
association between cognitive and institutional proximity with the number of internatio-
20
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theoretically suggested complementarity between geographical and other dimensions of
proximity. Similarly to Zitt et al. (2000), we ﬁnd that linguistic ties are positively related
to international scientiﬁc collaboration. However, we ﬁnd no robust support for a positive
relation between (past) colonial relations and research collaboration.
Our study should be supplemented by additional investigations addressing the determi-
nants of cross-country research collaboration in diﬀerent industries. Evidence from phar-
maceutical research may not be representative since pharmaceuticals diﬀer from other
industries in many respects, e.g., their scientiﬁc foundation and their internationaliza-
tion. Another limitation of this study arises from our dataset, which does not allow of
taking policy programs established to stimulate international research collaboration into
account. The objectives of these programs may be quite diverse. They may encompass
the establishment of an integrated research area in the case of the European Union as
well as the enhancement of scientiﬁc research in developing countries. Moreover, diﬀerent
types of organizations, e.g., universities and public research institutions as well as ﬁrms,
may diﬀer in their collaboration patterns. In contrast to universities, ﬁrms may be more
likely to engage in international research collaboration that takes place within one orga-
nization with R&D facilities in diﬀerent countries. This mode of international research
collaboration diﬀers from collaboration involving diﬀerent organizations. Future research
should therefore address diﬀerent types of international scientiﬁc collaborations on the
ﬁrm level.
21
Jena Economic Research Papers 2011 - 026A Appendix
A.1 List of Therapeutic Areas and Description of Variables
Therapeutic Area Therapeutic Area ID
Cancer 1
Cardiovascular 2
Central Nervous System 3
Dermatology 4











Table 3: List of Therapeutic Areas
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Collaborations Number of Collaborations between two countries
Explanatory Variables Proximity
log PubActor mass log of the number of publications of the actor country
log PubPartner mass log of the number of publications of the partner country
log distw geographical log of population weighted geographic distance
log PrevExperience social log of the cumulated number of previous collaborations between countries
log PrevSpecialCorr cognitive log of the cosine of country vectors containing the share of publications per the-
rapeutic area prior to the analysed period
log PrevResTypeCorr institutional log of country vector uncentered correlation containing the share of publications
per CHI level prior to the analysed period
comlang ethno cultural equals 1 if at least 9% of the population in both countries share the same language
colony cultural equals 1 if two countries had ever a colonial link
comcol cultural equals 1 if two countries had the same colonizer after 1945
smctry cultural equals 1 if two countries were part of the same country during their history
distExp Interaction term between log distw and log PrevExperience
distSpecial Interaction term between log distw and log PrevSpecialCorr
distResType Interaction term between log distw and log ResTypeCorr
Controls
contig equals 1 if two countries are contiguous
SmIncomeGr equals 1 if two collaborating countries belong the same Worldbank income group
Period Control equals 1 if collaboration is observed in period 2
Therap. Area Controls dummy variables for the diﬀerent therapeutic areas
Table 4: Description of Variables
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Jena Economic Research Papers 2011 - 026A.2 Descriptives and Correlations and Additional Regressions
Figure 2: Share of Cross-Country Collaborations per Region
Figure 3: Share of Cross-Country Collaborations per Income Group
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(1) log PubActor 1
(2) log PubPartner 0.0174∗ 1
(3) log distw -0.0439∗∗∗ -0.0421∗∗∗ 1
(4) log PrevExperience 0.379∗∗∗ 0.391∗∗∗ -0.298∗∗∗ 1
(5) log PrevSpecialCorr 0.156∗∗∗ 0.146∗∗∗ -0.0844∗∗∗ 0.214∗∗∗ 1
(6) log PrevResTypeCorr 0.193∗∗∗ 0.189∗∗∗ -0.145∗∗∗ 0.179∗∗∗ 0.144∗∗∗ 1
(7) comlang ethno -0.0406∗∗∗ -0.0366∗∗∗ -0.0488∗∗∗ 0.0474∗∗∗ -0.0149 -0.0524∗∗∗ 1
(8) colony 0.0790∗∗∗ 0.0985∗∗∗ -0.0573∗∗∗ 0.159∗∗∗ 0.0144 0.0251∗∗ 0.163∗∗∗ 1
(9) comcol -0.137∗∗∗ -0.135∗∗∗ -0.0534∗∗∗ -0.0815∗∗∗ -0.0310∗∗∗ -0.0629∗∗∗ 0.334∗∗∗ -0.0351∗∗∗ 1
(10) smctry -0.00216 -0.0103 -0.211∗∗∗ 0.0290∗∗∗ 0.0124 0.0113 0.0977∗∗∗ 0.0658∗∗∗ 0.101∗∗∗ 1
(11) contig 0.0288∗∗∗ 0.0279∗∗∗ -0.310∗∗∗ 0.129∗∗∗ 0.0447∗∗∗ 0.0356∗∗∗ 0.130∗∗∗ 0.129∗∗∗ 0.0731∗∗∗ 0.369∗∗∗ 1
(12) SmIncomeGr 0.0134 0.00394 -0.242∗∗∗ 0.252∗∗∗ 0.0979∗∗∗ 0.0533∗∗∗ 0.0211∗∗ -0.00674 0.0349∗∗∗ 0.0885∗∗∗ 0.139∗∗∗ 1
∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001
Table 5: Cross-correlation Table Without Therapeutic Areas Distinction
2
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(1) log PubActor 1
(2) log PubPartner 0.0962∗∗∗ 1
(3) log distw 0.0000510 -0.00109 1
(4) log PrevExperience 0.324∗∗∗ 0.329∗∗∗ -0.319∗∗∗ 1
(5) log PrevSpecialCorr 0.173∗∗∗ 0.181∗∗∗ -0.163∗∗∗ 0.201∗∗∗ 1
(6) log PrevResTypeCorr 0.0130∗∗ 0.0174∗∗∗ -0.107∗∗∗ 0.107∗∗∗ 0.110∗∗∗ 1
(7) comlang ethno 0.0159∗∗∗ 0.0193∗∗∗ 0.0135∗∗ 0.0739∗∗∗ -0.00293 -0.00203 1
(8) colony 0.0684∗∗∗ 0.0624∗∗∗ -0.0513∗∗∗ 0.105∗∗∗ 0.0353∗∗∗ 0.0104∗ 0.233∗∗∗ 1
(9) comcol -0.0809∗∗∗ -0.0787∗∗∗ -0.0230∗∗∗ -0.0469∗∗∗ -0.0707∗∗∗ 0.000916 0.256∗∗∗ -0.0278∗∗∗ 1
(10) smctry -0.0151∗∗∗ -0.0189∗∗∗ -0.209∗∗∗ 0.0172∗∗∗ 0.0243∗∗∗ 0.0111∗ 0.102∗∗∗ 0.102∗∗∗ 0.0615∗∗∗ 1
(11) contig 0.0263∗∗∗ 0.0277∗∗∗ -0.314∗∗∗ 0.116∗∗∗ 0.0689∗∗∗ 0.0299∗∗∗ 0.153∗∗∗ 0.176∗∗∗ 0.0454∗∗∗ 0.345∗∗∗ 1
(12) SmIncomeGr 0.0861∗∗∗ 0.0811∗∗∗ -0.306∗∗∗ 0.326∗∗∗ 0.213∗∗∗ 0.0841∗∗∗ 0.0173∗∗∗ 0.0108∗ -0.0144∗∗ 0.0502∗∗∗ 0.141∗∗∗ 1
∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001
Table 6: Cross-correlation Table with Distinguishing Therapeutic Areas
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98-02 98-02 98-02 04-08 04-08 04-08 Pooled Pooled Pooled
Dependent Variable: Number of Collaborations
log PubActor 0.485∗∗∗ 0.480∗∗∗ 0.484∗∗∗ 0.462∗∗∗ 0.479∗∗∗ 0.480∗∗∗ 0.476∗∗∗ 0.484∗∗∗ 0.486∗∗∗
log PubPartner 0.486∗∗∗ 0.488∗∗∗ 0.493∗∗∗ 0.498∗∗∗ 0.507∗∗∗ 0.505∗∗∗ 0.494∗∗∗ 0.501∗∗∗ 0.501∗∗∗
log distw -0.584∗∗∗ -0.600∗∗∗ -0.731∗∗∗ -0.724∗∗∗ -0.754∗∗∗ -0.920∗∗∗ -0.670∗∗∗ -0.699∗∗∗ -0.829∗∗∗
log PrevExperience 0.602∗∗∗ 0.559∗∗∗ 0.272 0.579∗∗∗ 0.533∗∗∗ 0.0108 0.586∗∗∗ 0.539∗∗∗ 0.136
log PrevSpecialCorr 0.203 0.292∗ 3.051∗∗ 0.273∗ 0.344∗∗ 1.137 0.247∗ 0.333∗∗∗ 1.613
log PrevResTypeCorr 1.070∗ 1.523∗∗∗ 6.842 0.164 0.237 2.933 0.317∗ 0.455∗∗ 2.742
comlang ethno 0.941∗∗∗ 0.960∗∗∗ 0.721∗∗∗ 0.704∗∗∗ 0.803∗∗∗ 0.798∗∗∗
colony 0.727∗∗∗ 0.751∗∗∗ 0.703∗∗∗ 0.660∗∗ 0.679∗∗∗ 0.659∗∗∗
comcol -0.511 -0.444 0.0766 0.0808 -0.122 -0.100
smctry -0.180 -0.241 -0.428 -0.366 -0.332 -0.290
distExp 0.0352 0.0660∗∗∗ 0.0510∗∗∗
distSpecial -0.325∗∗ -0.0958 -0.153
distResType -0.598 -0.311 -0.263
contig 0.0426 -0.115 0.0558 -0.196 -0.381∗ -0.360 -0.0847 -0.263 -0.220
SmIncomeGr 0.458∗∗∗ 0.525∗∗∗ 0.476∗∗∗ 0.139 0.164 0.166 0.291∗∗∗ 0.332∗∗∗ 0.316∗∗∗
Period Control No No No No No No Yes Yes Yes
cons -0.0674 0.00484 1.071 1.250∗∗∗ 1.319∗∗∗ 2.704∗∗∗ 0.660∗ 0.741∗∗ 1.821∗∗∗
lnalpha
cons 1.179∗∗∗ 1.103∗∗∗ 1.087∗∗∗ 0.835∗∗∗ 0.783∗∗∗ 0.775∗∗∗ 0.983∗∗∗ 0.925∗∗∗ 0.918∗∗∗
N 7319 7319 7319 6697 6697 6697 14016 14016 14016
AIC 12251.7 12112.7 12095.2 17017.5 16883.4 16858.4 29314.6 29049.0 29019.0
BIC 12320.7 12209.3 12212.5 17085.6 16978.7 16974.1 29397.6 29162.2 29154.8
Log pseudolikelihood -6115.851 -6042.343 -6030.601 -8498.75 -8427.694 -8412.192 -14646.294 -14509.484 -14491.487
∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001
Table 7: Negative Binomial Regression Models Without Therapeutic Area Distinction
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98-02 98-02 98-02 04-08 04-08 04-08 Pooled Pooled Pooled
Dependent Variable: Number of Collaborations
log PubActor 0.342∗∗∗ 0.357∗∗∗ 0.364∗∗∗ 0.360∗∗∗ 0.378∗∗∗ 0.385∗∗∗ 0.358∗∗∗ 0.374∗∗∗ 0.381∗∗∗
log PubPartner 0.340∗∗∗ 0.357∗∗∗ 0.367∗∗∗ 0.374∗∗∗ 0.391∗∗∗ 0.395∗∗∗ 0.366∗∗∗ 0.384∗∗∗ 0.389∗∗∗
log distw -0.417∗∗∗ -0.460∗∗∗ -0.479∗∗∗ -0.495∗∗∗ -0.535∗∗∗ -0.588∗∗∗ -0.464∗∗∗ -0.507∗∗∗ -0.538∗∗∗
log PrevExperience 0.520∗∗∗ 0.489∗∗∗ 0.587∗∗∗ 0.536∗∗∗ 0.512∗∗∗ 0.461∗∗∗ 0.525∗∗∗ 0.497∗∗∗ 0.518∗∗∗
log PrevSpecialCorr -0.140 -0.0536 3.171∗∗ -0.362∗∗ -0.311∗ 0.701 -0.304∗∗∗ -0.228∗ 1.520
log PrevResTypeCorr -0.0861 0.342 4.189 -0.238 -0.178 2.802 -0.114 0.0152 2.242
comlang ethno 0.724∗∗∗ 0.761∗∗∗ 0.394∗∗∗ 0.422∗∗∗ 0.535∗∗∗ 0.561∗∗∗
colony 0.114 0.137 0.257∗ 0.241∗ 0.201∗ 0.192∗
comcol -0.494 -0.423 0.150 0.195 -0.0756 -0.0244
smctry -0.119 -0.128 -0.280 -0.218 -0.215 -0.156
distExp -0.0151 0.00520 -0.00429
distSpecial -0.387∗∗ -0.125 -0.212
distResType -0.420 -0.339 -0.252
contig -0.240 -0.357 -0.204 -0.431∗∗∗ -0.517∗∗∗ -0.450∗∗ -0.340∗∗ -0.442∗∗ -0.360∗
SmIncomeGr 0.461∗∗∗ 0.509∗∗∗ 0.503∗∗∗ 0.246∗∗ 0.268∗∗∗ 0.264∗∗∗ 0.359∗∗∗ 0.389∗∗∗ 0.383∗∗∗
Period Control No No No No No No Yes Yes Yes
constant 0.570∗ 0.695∗ 0.769 0.876∗∗∗ 0.969∗∗∗ 1.342∗∗ 0.651∗∗∗ 0.777∗∗∗ 0.957∗∗
Zero-inﬂated Part (logit)
log distw 0.156∗ 0.129∗ 0.215∗∗ 0.659∗∗∗ 0.625∗∗∗ 0.673∗∗∗ 0.409∗∗∗ 0.376∗∗∗ 0.434∗∗∗
log PrevExperience -1.809∗∗∗ -1.789∗∗∗ -1.802∗∗∗ -1.518∗∗∗ -1.518∗∗∗ -1.535∗∗∗ -1.617∗∗∗ -1.608∗∗∗ -1.623∗∗∗
log PrevSpecialCorr -0.580∗∗∗ -0.528∗∗ -0.577∗∗ -1.622∗∗∗ -1.597∗∗∗ -1.624∗∗∗ -1.161∗∗∗ -1.126∗∗∗ -1.151∗∗∗
log PrevResTypeCorr -3.031∗∗∗ -2.770∗∗∗ -2.623∗∗∗ -1.010∗∗∗ -0.985∗∗∗ -0.944∗∗∗ -1.167∗∗∗ -1.097∗∗∗ -1.071∗∗∗
constant -0.877 -0.713 -1.444∗ -5.925∗∗∗ -5.682∗∗∗ -6.111∗∗∗ -3.369∗∗∗ -3.146∗∗∗ -3.652∗∗∗
lnalpha
constant 0.239∗ 0.240∗ 0.223∗ 0.0530 0.0554 0.0609 0.148∗∗ 0.153∗∗ 0.151∗∗
N 7319 7319 7319 6697 6697 6697 14016 14016 14016
AIC 11802.2 11737.7 11719.1 16299.1 16258.7 16252.3 28224.0 28119.0 28096.7
BIC 11905.6 11868.7 11870.8 16401.3 16388.0 16402.1 28344.8 28269.9 28270.3
Log pseudolikelihood -5886.08 -5849.838 -5837.532 -8134.573 -8110.328 -8104.163 -14096.02 -14039.48 -14025.34
∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001
Table 8: Zero-inﬂated Negative Binomial Regression Models Without Therapeutic Area Distinction
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